Home/Filings/4/0001213900-20-026095
4//SEC Filing

GERMAIN MARK 4

Accession 0001213900-20-026095

CIK 0001158780other

Filed

Sep 9, 8:00 PM ET

Accepted

Sep 10, 5:12 PM ET

Size

5.3 KB

Accession

0001213900-20-026095

Insider Transaction Report

Form 4
Period: 2020-09-10
GERMAIN MARK
Director
Transactions
  • Award

    Restricted Stock Units

    2020-09-10+20,00082,569 total
Footnotes (3)
  • [F1]Each RSU represents a contingent right to receive one share of the Issuer's common stock.
  • [F2]The shares vest over four years as follows: 12.5% shall vest on the 6 month anniversary of the date of grant and the remaining shares vest in 14 equal installments every 3 months thereafter.
  • [F3]Such number of shares of common stock have been adjusted to reflect the reverse stock split that occurred on July 25, 2019.

Issuer

PLURISTEM THERAPEUTICS INC

CIK 0001158780

Entity typeother

Related Parties

1
  • filerCIK 0001195498

Filing Metadata

Form type
4
Filed
Sep 9, 8:00 PM ET
Accepted
Sep 10, 5:12 PM ET
Size
5.3 KB